Search
Rxsight Inc
RXSTAdd to Watchlist
4.760USD
+0.080+1.71%
Close 10-05 16:00（ET）
197.06MMarket Cap
LossP/E TTM
Rxsight Inc (RXST) Stock Price Target & Forecast
Analyst Rating
Based on 10 analysts giving stock ratings to Rxsight Inc in the past month.
Hold
0 Strong Buy
1 Buy
7 Hold
2 Sell
0 Strong Sell
Target Price
7.793USD+66.51%
RXST Analyst Recommendation Trends
In the current month, RXST has received 1 Buy Ratings, 7 Hold Ratings, and 2 Sell Ratings. RXST average Analyst price target in the last month is 7.793.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
7
7
8
8
9
8
8
8
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
10
10
11
11
12
11
11
11
RXST Analyst Rating for Peer Comparison
Updated: Oct 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Dexcom Inc
DXCM
13
12
4
0
0
29
Stryker Corp
SYK
11
13
5
0
0
29
Medtronic PLC
MDT
8
11
10
0
0
29
Abbott Laboratories
ABT
11
13
4
0
0
28
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Zimmer Biomet Holdings Inc
ZBH
2
6
20
0
0
28
Guardant Health Inc
GH
12
13
2
0
0
27
Insulet Corp
PODD
10
12
5
0
0
27
Tandem Diabetes Care Inc
TNDM
5
8
10
0
0
23
Repligen Corp
RGEN
5
14
3
0
0
22
Financial Forecasting
Based on analysts' estimates, RXST EPS is projected to reach -0.268 in FY2026Q3, following reported EPS of -0.292 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.33
-0.28
-0.33
-0.27
0.00
Actual
-0.22
-0.38
-0.29
--
--
Surprise
+33.12%
-36.63%
+11.62%
--
--
FAQs
What is Rxsight Inc's expected revenue for the next quarter?
Rxsight Inc's expected revenue is 27.14M.
What is Rxsight Inc's price target?
Analysts forecast that Rxsight Inc's price target is USD 7.79, with the highest forecast at USD 11.00 and the lowest forecast at USD 5.50.
How have Rxsight IncRXST's recent earnings per share performed?
The market expectation was USD -0.29, while Rxsight IncRXST's earnings per share (EPS) for the previous quarter was USD -0.38. EPS for the next quarter is expected at USD -0.27.
What is the analyst rating for Rxsight Inc?
Based on the ratings of Rxsight Inc's stock from 10 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.